000 01385 a2200385 4500
005 20250513111610.0
264 0 _c19970218
008 199702s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/s0959-8049(96)00222-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarbareschi, M
245 0 0 _ap21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cNov 1996
300 _a2182-3 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCyclin-Dependent Kinase Inhibitor p21
650 0 4 _aCyclins
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoplasm Proteins
_xmetabolism
650 0 4 _aSurvival Rate
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
700 1 _aDoglioni, C
700 1 _aVeronese, S
700 1 _aBonzanini, M
700 1 _aDalla Palma, P
700 1 _aHarris, A L
700 1 _aCaffo, O
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 32A
_gno. 12
_gp. 2182-3
856 4 0 _uhttps://doi.org/10.1016/s0959-8049(96)00222-5
_zAvailable from publisher's website
999 _c9005439
_d9005439